Location: Home
  • search
  • go
  • Relate News
  • 2/6/2026Merck's Keytruda Wins New China Approval for Frontline Endometrial Can...
  • 2/6/2026Kelun-Biotech Expands Breast Cancer Indications of sac-TMT in China
  • 2/5/2026CDE Issues Technical Guideline for Clinical Trials of Chronic Insomnia...
  • 2/5/2026Shanghai Pharma Exits BMS China, Closing a Chapter for JV Pharma in Ch...
  • 2/5/2026iMBioRay Raises Nearly CNY 200M Series B to Advance NK Cell Therapy P...
  • 2/5/2026Eisai Secures Exclusive Rights to Henlius' Anti-PD-1 Antibody Serpluli...
  • 2/5/2026Everest Medicines Licenses Micot's MT1013 for SHPT in China and Asia-P...
  • 2/5/2026Evogene and Lishan Biopharma Partner to Develop Microbiome Therapy for...
  • 2/5/2026AmCham China Hosts US FDA Delegation to Strengthen Regulatory Dialogue
  • 2/5/2026Fosun Secures Priority Review in China for Luvometinib's New Indicatio...
  • 2/5/2026Novo Nordisk Reports First Decline in Ozempic Sales in Greater China
  • 2/5/2026China Biotech Emerges as Global Deal Powerhouse, Analysts Cite Strong ...
  • 2/5/2026Global Pharma in 2025: China Remains a Key Market Amid Rising Competit...
  • 2/4/2026CMS Gets Green Light from NMPA to Launch Trials for Novel Kidney Disea...
  • 2/4/2026Bayer's Nubeqa Gains Third Approval in China for Advanced Prostate Can...
  • 2/4/2026China's Health Insurance Market Poised for $596B Surge by 2033
  • 2/4/2026Almirall's Seysara Approved in China for Moderate-to-Severe Acne
  • 2/4/2026WuXi Biologics and Sinorda Join Forces to Develop Bispecific Antibody ...
  • 2/4/2026Novartis Secures Global Rights to SciNeuro’s Next-Gen Alzheimer’s An...
  • 2/4/2026Vertex Takes Global Control of WuXi Biologics Trispecific T-Cell Engag...
  • 2/4/2026Innovent Advances IL-15 Antibody IBI3013 Into Clinical Trials for Viti...
  • 2/3/2026China Tightens BMI Fund Oversight for 2026 With Nationwide Crackdown o...
  • 2/3/2026China and USFDA Officials Pledge to Deepen Regulatory Cooperation at B...
  • 2/3/2026Hengrui's Camrelizumab Combo Accepted by FDA for First-Line Liver Canc...
  • 2/3/2026New Indication for Novartis' Secukinumab in Non-Radiographic Axial Spo...
  • 2/3/2026HSG Completes Global Acquisition of Avelox and Launches Anti-Infective...
  • 2/3/2026Beijing-Based PrimeGenX Therapeutics' HKSE IPO Application Accepted
  • 1/31/2026Recent Official and Executive Moves
  • 1/30/2026Formation Bio Licenses Oral miR-124 Activator FHND5032 from CTFH for A...
  • 1/30/2026CMS Secures NMPA Approval for Opzelura in Non-Segmental Vitiligo
  • Page:2/380 Total number of articles:11375: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group